Question 1

What is a life sciences compliance and quality platform?

Accepted Answer

A life sciences compliance and quality platform is software that automates and manages quality management system (QMS) processes including audit management, CAPA (corrective and preventive action) tracking, deviation management, change control, document management, and GxP training records. It replaces paper-based and spreadsheet-driven QMS workflows with a validated digital system that maintains audit trails, enforces review and approval workflows, and provides compliance reporting across facilities and markets.

Question 2

What is GxP compliance in pharma?

Accepted Answer

GxP refers to a set of good practice regulations and guidelines applicable across the pharmaceutical, medical device, and life sciences industries. Key GxP standards include GMP (Good Manufacturing Practice), GCP (Good Clinical Practice), GLP (Good Laboratory Practice), and GDP (Good Distribution Practice). GxP compliance requires documented systems, trained personnel, validated equipment and software, controlled processes, and comprehensive audit trails demonstrating that products are consistently produced, stored, and distributed to meet quality standards.

Question 3

What is 21 CFR Part 11 and how does it apply to compliance software?

Accepted Answer

21 CFR Part 11 is the US FDA regulation governing electronic records and electronic signatures in pharmaceutical and life sciences companies. It requires that electronic records used to demonstrate compliance with FDA regulations are trustworthy, reliable, and equivalent to paper records. Compliance software must implement access controls, audit trails, system validation, electronic signature controls with identity authentication, and data integrity protections. Vendors targeting pharma customers must provide a 21 CFR Part 11 compliance assessment and IQ/OQ/PQ validation support.

Question 4

What is CAPA management in pharmaceutical quality systems?

Accepted Answer

CAPA (Corrective and Preventive Action) management is the systematic process for identifying, investigating, and eliminating the root causes of quality events — including deviations, non-conformances, audit findings, and customer complaints. A CAPA workflow captures the event, assigns responsibility for root cause analysis, documents the corrective action plan, tracks implementation milestones, and verifies effectiveness through follow-up assessment. Regulatory inspectors scrutinise CAPA systems as a key indicator of a company's quality culture and systemic problem-solving capability.

Question 5

How does a quality management system (QMS) support pharmaceutical audits?

Accepted Answer

A digital QMS supports pharmaceutical audits by maintaining comprehensive, searchable records of all quality events, CAPAs, change controls, training records, and audit findings in a single system. Audit management modules coordinate supplier audit scheduling, generate audit reports, track finding remediation, and provide audit history dashboards. During regulatory inspections, a validated QMS enables rapid retrieval of required documentation, demonstrates systematic quality processes, and provides evidence of ongoing CAPA closure rates and effectiveness.

Question 6

What is change control in pharmaceutical manufacturing?

Accepted Answer

Change control is the formal process for evaluating, approving, implementing, and documenting changes to GxP-controlled processes, equipment, facilities, systems, or documentation. It ensures changes are assessed for their potential impact on product quality, patient safety, and regulatory compliance before implementation. A change control workflow routes the change request through risk assessment, technical review, regulatory impact assessment, and approval steps, then tracks implementation and closure — maintaining a complete audit trail for regulatory inspection.

Question 7

How long does it take to implement a pharmaceutical quality management system?

Accepted Answer

Implementing a validated QMS for a pharmaceutical company typically takes 4–12 weeks for a template-based platform deployment, depending on the number of modules, site scope, and validation requirements. The validation process (IQ/OQ/PQ) for a cloud-based, pre-validated QMS platform typically adds 2–4 weeks. Custom-built QMS systems may take 12–24 months or longer. Platform-based approaches reduce timelines significantly by providing pre-configured workflows, pre-validated system documentation, and configurable — rather than custom-coded — processes.

Inspection-ready. Every day, not just audit day.

Compliance teams are drowning in documentation, not decisions.

From policy to proof. Continuously.

Policies and SOPs are the foundation — if anyone can find them

Always inspection-ready. Not just on audit day.

Your compliance gaps. Your regulatory landscape.

Proven in regulated environments.

A global pharma company's quality team was spending 60% of their time preparing for inspections — assembling audit packages manually from five different systems.

Everything we can deploy for Compliance & Quality.

Compliance Monitoring & Risk

Global PSP Compliance

Compliance Co-Pilot

Events Compliance

Promotional Review (PRC/MLR)

Third-Party Due Diligence

Clinical Trial Transparency

Code of Conduct & Ethics

Compassionate Access

Pharmacovigilance & AE Management

Frequently asked questions